18 0 2 0 2 B-lower_bound
to 3 5 3 5 O
75 6 8 6 8 B-upper_bound
years 9 14 9 14 I-upper_bound
of 15 17 15 17 O
age 18 21 18 21 B-age
at 22 24 22 24 O
the 25 28 25 28 O
time 29 33 29 33 O
of 34 36 34 36 O
screening 37 46 37 46 O

18 0 2 47 49 B-lower_bound
years 3 8 50 55 I-lower_bound
of 9 11 56 58 O
age 12 15 59 62 B-age
or 16 18 63 65 O
older 19 24 66 71 O
at 25 27 72 74 O
the 28 31 75 78 O
time 32 36 79 83 O
of 37 39 84 86 O
screening 40 49 87 96 O

Documented 0 10 97 107 O
Alpha1 11 17 108 114 B-treatment
- 17 18 114 115 I-treatment
Proteinase 18 28 115 125 I-treatment
Inhibitor 29 38 126 135 I-treatment
( 39 40 136 137 I-treatment
A1PI 40 44 137 141 I-treatment
) 44 45 141 142 I-treatment
genotype 46 54 143 151 O
of 55 57 152 154 O
Pi*Z 58 62 155 159 O
/ 62 63 159 160 O
Z 63 64 160 161 O
, 64 65 161 162 O
Pi*Z 66 70 163 167 O
/ 70 71 167 168 O
Null 71 75 168 172 O
, 75 76 172 173 O
Pi*Malton 77 86 174 183 O
/ 86 87 183 184 O
Z 87 88 184 185 O
, 88 89 185 186 O
Pi*Null 90 97 187 194 O
/ 97 98 194 195 O
Null 98 102 195 199 O
, 102 103 199 200 O
or 104 106 201 203 O
other 107 112 204 209 O
at 113 115 210 212 O
- 115 116 212 213 O
risk 116 120 213 217 O
allelic 121 128 218 225 O
combinations 129 141 226 238 O
such 142 146 239 243 O
as 147 149 244 246 O
SZ 150 152 247 249 O
( 153 154 250 251 O
excluding 154 163 251 260 O
MS 164 166 261 263 O
and 167 170 264 267 O
MZ 171 173 268 270 O
) 173 174 270 271 O
and 175 178 272 275 O
an 179 181 276 278 O
endogenous 182 192 279 289 B-clinical_variable
A1PI 193 197 290 294 I-clinical_variable
plasma 198 204 295 301 I-clinical_variable
levels 205 211 302 308 I-clinical_variable
of 212 214 309 311 O
≤11 215 218 312 315 O
μM 219 221 316 318 I-upper_bound

For 0 3 319 322 O
participants 4 16 323 335 O
who 17 20 336 339 O
will 21 25 340 344 O
be 26 28 345 347 O
waived 29 35 348 354 O
from 36 40 355 359 O
undergoing 41 51 360 370 O
bronchoscopy 52 64 371 383 B-treatment
/ 64 65 383 384 O
BAL 65 68 384 387 B-treatment
procedures 69 79 388 398 I-treatment

For 0 3 399 402 O
participants 4 16 403 415 O
who 17 20 416 419 O
will 21 25 420 424 O
undergo 26 33 425 432 O
bronchoscopy/ 34 47 433 446 B-treatment
bronchoalveolar 48 63 447 462 B-treatment
lavage 64 70 463 469 I-treatment
( 71 72 470 471 I-treatment
BAL 72 75 471 474 I-treatment
) 75 76 474 475 I-treatment
procedures 77 87 476 486 I-treatment

If 0 2 487 489 O
a 3 4 490 491 O
participant 5 16 492 503 O
is 17 19 504 506 O
receiving 20 29 507 516 O
anticoagulant 30 43 517 530 B-treatment
or 44 46 531 533 O
anti 47 51 534 538 B-treatment
- 51 52 538 539 I-treatment
platelet 52 60 539 547 I-treatment
therapy 61 68 548 555 I-treatment
( 69 70 556 557 O
such 70 74 557 561 O
as 75 77 562 564 O
warfarin 78 86 565 573 B-treatment
and 87 90 574 577 O
clopidogrel 91 102 578 589 B-treatment
) 102 103 589 590 O
, 103 104 590 591 O
the 105 108 592 595 O
participant 109 120 596 607 O
is 121 123 608 610 O
unwilling 124 133 611 620 O
to 134 136 621 623 O
or 137 139 624 626 O
unable 140 146 627 633 O
to 147 149 634 636 O
safely 150 156 637 643 O
discontinue 157 168 644 655 O
anticoagulant 169 182 656 669 O
or 183 185 670 672 O
anti 186 190 673 677 O
- 190 191 677 678 O
platelet 191 199 678 686 O
therapy 200 207 687 694 O
within 208 214 695 701 O
7 215 216 702 703 B-upper_bound
days 217 221 704 708 I-upper_bound
prior 222 227 709 714 I-upper_bound
to 228 230 715 717 O
until 231 236 718 723 O
at 237 239 724 726 O
least 240 245 727 732 O
24 246 248 733 735 B-lower_bound
hours 249 254 736 741 I-lower_bound
after 255 260 742 747 I-lower_bound
the 261 264 748 751 O
BAL 265 268 752 755 B-treatment
procedures 269 279 756 766 I-treatment
. 279 280 766 767 O
An 281 283 768 770 O
exception 284 293 771 780 O
is 294 296 781 783 O
low 297 300 784 787 B-treatment
- 300 301 787 788 I-treatment
dose 301 305 788 792 I-treatment
aspirin 306 313 793 800 I-treatment
alone 314 319 801 806 O
which 320 325 807 812 O
is 326 328 813 815 O
allowed 329 336 816 823 O

Immunoglobulin 0 14 824 838 B-clinical_variable
A 15 16 839 840 I-clinical_variable
( 17 18 841 842 I-clinical_variable
IgA 18 21 842 845 I-clinical_variable
) 21 22 845 846 I-clinical_variable
deficiency 23 33 847 857 I-clinical_variable
( 34 35 858 859 O
< 35 36 859 860 O
8 36 37 860 861 B-upper_bound
mg 38 40 862 864 I-upper_bound
/ 40 41 864 865 I-upper_bound
dL 41 43 865 867 I-upper_bound
at 44 46 868 870 O
screening 47 56 871 880 O
) 56 57 880 881 O

Known 0 5 882 887 O
history 6 13 888 895 O
of 14 16 896 898 O
allergic 17 25 899 907 O
/ 25 26 907 908 O
hypersensitivity 26 42 908 924 O
reactions 43 52 925 934 O
to 53 55 935 937 O
medications 56 67 938 949 B-allergy_name
used 68 72 950 954 O
during 73 79 955 961 O
and 80 83 962 965 O
for 84 87 966 969 O
perioperative 88 101 970 983 O
care 102 106 984 988 O
associated 107 117 989 999 O
with 118 122 1000 1004 O
the 123 126 1005 1008 O
bronchoscopy 127 139 1009 1021 B-treatment
/ 139 140 1021 1022 O
BAL 140 143 1022 1025 B-treatment
procedures 144 154 1026 1036 I-treatment
, 154 155 1036 1037 O
such 156 160 1038 1042 O
as 161 163 1043 1045 O
local 164 169 1046 1051 B-allergy_name
anesthetics 170 181 1052 1063 I-allergy_name
, 181 182 1063 1064 O
sedatives 183 192 1065 1074 B-allergy_name
, 192 193 1074 1075 O
pain 194 198 1076 1080 B-allergy_name
control 199 206 1081 1088 I-allergy_name
medication 207 217 1089 1099 I-allergy_name

Known 0 5 1100 1105 O
history 6 13 1106 1113 O
of 14 16 1114 1116 O
hypersensitivity 17 33 1117 1133 O
following 34 43 1134 1143 O
infusions 44 53 1144 1153 B-allergy_name
of 54 56 1154 1156 I-allergy_name
human 57 62 1157 1162 I-allergy_name
blood 63 68 1163 1168 I-allergy_name
or 69 71 1169 1171 I-allergy_name
blood 72 77 1172 1177 I-allergy_name
components 78 88 1178 1188 I-allergy_name

Male 0 4 1189 1193 B-gender

Ongoing 0 7 1194 1201 O
active 8 14 1202 1208 B-chronic_disease
infection 15 24 1209 1218 I-chronic_disease
with 25 29 1219 1223 O
hepatitis 30 39 1224 1233 B-chronic_disease
A 40 41 1234 1235 I-chronic_disease
virus 42 47 1236 1241 I-chronic_disease
( 48 49 1242 1243 I-chronic_disease
HAV 49 52 1243 1246 I-chronic_disease
) 52 53 1246 1247 I-chronic_disease
, 53 54 1247 1248 O
hepatitis 55 64 1249 1258 B-chronic_disease
B 65 66 1259 1260 I-chronic_disease
virus 67 72 1261 1266 I-chronic_disease
( 73 74 1267 1268 I-chronic_disease
HBV 74 77 1268 1271 I-chronic_disease
) 77 78 1271 1272 I-chronic_disease
, 78 79 1272 1273 O
hepatitis 80 89 1274 1283 B-chronic_disease
C 90 91 1284 1285 I-chronic_disease
virus 92 97 1286 1291 I-chronic_disease
( 98 99 1292 1293 I-chronic_disease
HCV 99 102 1293 1296 I-chronic_disease
) 102 103 1296 1297 I-chronic_disease
, 103 104 1297 1298 O
or 105 107 1299 1301 O
human 108 113 1302 1307 B-chronic_disease
immunodeficiency 114 130 1308 1324 I-chronic_disease
virus 131 136 1325 1330 I-chronic_disease
( 137 138 1331 1332 I-chronic_disease
HIV 138 141 1332 1335 I-chronic_disease
) 141 142 1335 1336 I-chronic_disease
Type 143 147 1337 1341 I-chronic_disease
1 148 149 1342 1343 I-chronic_disease
or 150 152 1344 1346 I-chronic_disease
2 153 154 1347 1348 I-chronic_disease
infection 155 164 1349 1358 O
at 165 167 1359 1361 O
the 168 171 1362 1365 O
time 172 176 1366 1370 O
of 177 179 1371 1373 O
screening 180 189 1374 1383 O

Participants 0 12 1384 1396 O
must 13 17 1397 1401 O
have 18 22 1402 1406 O
at 23 25 1407 1409 O
least 26 31 1410 1415 O
one 32 35 1416 1419 B-lower_bound
of 36 38 1420 1422 O
the 39 42 1423 1426 O
following 43 52 1427 1436 O
: 52 53 1436 1437 O
clinical 54 62 1438 1446 O
diagnosis 63 72 1447 1456 O
of 73 75 1457 1459 O
emphysema 76 85 1460 1469 B-chronic_disease
, 85 86 1469 1470 O
evidence 87 95 1471 1479 O
of 96 98 1480 1482 O
emphysema 99 108 1483 1492 O
on 109 111 1493 1495 O
computerized 112 124 1496 1508 B-treatment
tomography 125 135 1509 1519 I-treatment
( 136 137 1520 1521 I-treatment
CT 137 139 1521 1523 I-treatment
) 139 140 1523 1524 I-treatment
scan 141 145 1525 1529 I-treatment
of 146 148 1530 1532 O
the 149 152 1533 1536 O
chest 153 158 1537 1542 O
, 158 159 1542 1543 O
and/or 160 166 1544 1550 O
evidence 167 175 1551 1559 O
of 176 178 1560 1562 O
airway 179 185 1563 1569 O
obstruction 186 197 1570 1581 O
which 198 203 1582 1587 O
is 204 206 1588 1590 O
not 207 210 1591 1594 O
completely 211 221 1595 1605 O
reversed 222 230 1606 1614 O
with 231 235 1615 1619 O
bronchodilator 236 250 1620 1634 B-treatment
treatment 251 260 1635 1644 I-treatment
at 261 263 1645 1647 O
the 264 267 1648 1651 O
time 268 272 1652 1656 O
of 273 275 1657 1659 O
screening 276 285 1660 1669 O

Screening 0 9 1670 1679 O
levels 10 16 1680 1686 O
of 17 19 1687 1689 O
endogenous 20 30 1690 1700 B-clinical_variable
plasma 31 37 1701 1707 I-clinical_variable
( 38 39 1708 1709 I-clinical_variable
antigenic 39 48 1709 1718 I-clinical_variable
) 48 49 1718 1719 I-clinical_variable
A1PI 50 54 1720 1724 I-clinical_variable
of 55 57 1725 1727 O
≤11 58 61 1728 1731 O
μM 62 64 1732 1734 I-upper_bound
may 65 68 1735 1738 O
be 69 71 1739 1741 O
collected 72 81 1742 1751 O
at 82 84 1752 1754 O
any 85 88 1755 1758 O
time 89 93 1759 1763 O
during 94 100 1764 1770 O
the 101 104 1771 1774 O
screening 105 114 1775 1784 O
period 115 121 1785 1791 O
for 122 125 1792 1795 O
treatment 126 135 1796 1805 B-treatment
- 135 136 1805 1806 O
naïve 136 141 1806 1811 O
participants 142 154 1812 1824 O
, 154 155 1824 1825 O
or 156 158 1826 1828 O
following 159 168 1829 1838 O
a 169 170 1839 1840 O
4 171 172 1841 1842 B-lower_bound
week 173 177 1843 1847 I-lower_bound
minimum 178 185 1848 1855 O
wash 186 190 1856 1860 O
- 190 191 1860 1861 O
out 191 194 1861 1864 O
from 195 199 1865 1869 O
previous 200 208 1870 1878 B-treatment
augmentation 209 221 1879 1891 I-treatment
therapy 222 229 1892 1899 I-treatment
in 230 232 1900 1902 O
treatment 233 242 1903 1912 O
- 242 243 1912 1913 O
experienced 243 254 1913 1924 O
participants 255 267 1925 1937 O

The 0 3 1938 1941 O
participant 4 15 1942 1953 O
has 16 19 1954 1957 O
a 20 21 1958 1959 O
history 22 29 1960 1967 O
of 30 32 1968 1970 O
frequent 33 41 1971 1979 O
pulmonary 42 51 1980 1989 B-chronic_disease
exacerbations 52 65 1990 2003 I-chronic_disease
( 66 67 2004 2005 O
greater 67 74 2005 2012 O
than 75 79 2013 2017 O
2 80 81 2018 2019 B-lower_bound
moderate 82 90 2020 2028 O
or 91 93 2029 2031 O
severe 94 100 2032 2038 O
exacerbations 101 114 2039 2052 O
within 115 121 2053 2059 O
52 122 124 2060 2062 B-upper_bound
weeks 125 130 2063 2068 I-upper_bound
prior 131 136 2069 2074 I-upper_bound
to 137 139 2075 2077 O
screening 140 149 2078 2087 O

The 0 3 2088 2091 O
participant 4 15 2092 2103 O
has 16 19 2104 2107 O
a 20 21 2108 2109 O
history 22 29 2110 2117 O
of 30 32 2118 2120 O
lung 33 37 2121 2125 B-treatment
or 38 40 2126 2128 O
other 41 46 2129 2134 O
organ 47 52 2135 2140 B-treatment
transplant 53 63 2141 2151 I-treatment
, 63 64 2151 2152 O
is 65 67 2153 2155 O
currently 68 77 2156 2165 O
on 78 80 2166 2168 O
a 81 82 2169 2170 O
transplant 83 93 2171 2181 O
list 94 98 2182 2186 O
, 98 99 2186 2187 O
or 100 102 2188 2190 O
has 103 106 2191 2194 O
undergone 107 116 2195 2204 O
major 117 122 2205 2210 B-treatment
lung 123 127 2211 2215 I-treatment
surgery 128 135 2216 2223 I-treatment

The 0 3 2224 2227 O
participant 4 15 2228 2239 O
has 16 19 2240 2243 O
any 20 23 2244 2247 O
clinically 24 34 2248 2258 O
significant 35 46 2259 2270 O
medical 47 54 2271 2278 B-chronic_disease
, 54 55 2278 2279 O
psychiatric 56 67 2280 2291 B-chronic_disease
, 67 68 2291 2292 O
or 69 71 2293 2295 O
cognitive 72 81 2296 2305 B-chronic_disease
illness 82 89 2306 2313 I-chronic_disease
, 89 90 2313 2314 O
or 91 93 2315 2317 O
any 94 97 2318 2321 O
other 98 103 2322 2327 O
uncontrolled 104 116 2328 2340 O
medical 117 124 2341 2348 O
condition 125 134 2349 2358 O
( 135 136 2359 2360 O
eg 136 138 2360 2362 O
, 138 139 2362 2363 O
unstable 140 148 2364 2372 B-chronic_disease
angina 149 155 2373 2379 I-chronic_disease
, 155 156 2379 2380 O
transient 157 166 2381 2390 B-chronic_disease
ischemic 167 175 2391 2399 I-chronic_disease
attack 176 182 2400 2406 I-chronic_disease
) 182 183 2406 2407 O
that 184 188 2408 2412 O
, 188 189 2412 2413 O
in 190 192 2414 2416 O
the 193 196 2417 2420 O
opinion 197 204 2421 2428 O
of 205 207 2429 2431 O
the 208 211 2432 2435 O
investigator 212 224 2436 2448 O
, 224 225 2448 2449 O
would 226 231 2450 2455 O
impede 232 238 2456 2462 O
the 239 242 2463 2466 O
participant 243 254 2467 2478 O
's 254 256 2478 2480 O
ability 257 264 2481 2488 O
to 265 267 2489 2491 O
comply 268 274 2492 2498 O
with 275 279 2499 2503 O
the 280 283 2504 2507 O
study 284 289 2508 2513 O
procedures 290 300 2514 2524 O
, 300 301 2524 2525 O
pose 302 306 2526 2530 O
increased 307 316 2531 2540 O
risk 317 321 2541 2545 O
to 322 324 2546 2548 O
the 325 328 2549 2552 O
participant 329 340 2553 2564 O
's 340 342 2564 2566 O
safety 343 349 2567 2573 O
, 349 350 2573 2574 O
or 351 353 2575 2577 O
confound 354 362 2578 2586 O
the 363 366 2587 2590 O
interpretation 367 381 2591 2605 O
of 382 384 2606 2608 O
study 385 390 2609 2614 O
results 391 398 2615 2622 O

The 0 3 2623 2626 O
participant 4 15 2627 2638 O
has 16 19 2639 2642 O
clinically 20 30 2643 2653 O
significant 31 42 2654 2665 O
abnormalities 43 56 2666 2679 O
( 57 58 2680 2681 O
other 58 63 2681 2686 O
than 64 68 2687 2691 O
emphysema 69 78 2692 2701 B-chronic_disease
, 78 79 2701 2702 O
chronic 80 87 2703 2710 B-chronic_disease
bronchitis 88 98 2711 2721 I-chronic_disease
, 98 99 2721 2722 O
or 100 102 2723 2725 O
mild 103 107 2726 2730 B-chronic_disease
bronchiectasis 108 122 2731 2745 I-chronic_disease
) 122 123 2745 2746 O
detected 124 132 2747 2755 O
on 133 135 2756 2758 O
chest 136 141 2759 2764 O
X 142 143 2765 2766 B-treatment
- 143 144 2766 2767 I-treatment
ray 144 147 2767 2770 I-treatment
or 148 150 2771 2773 O
CT 151 153 2774 2776 B-treatment
scan 154 158 2777 2781 I-treatment
at 159 161 2782 2784 O
the 162 165 2785 2788 O
time 166 170 2789 2793 O
of 171 173 2794 2796 O
screening 174 183 2797 2806 O
. 183 184 2806 2807 O
( 185 186 2808 2809 O
Past 186 190 2809 2813 O
records 191 198 2814 2821 O
obtained 199 207 2822 2830 O
within 208 214 2831 2837 O
52 215 217 2838 2840 B-upper_bound
weeks 218 223 2841 2846 I-upper_bound
prior 224 229 2847 2852 I-upper_bound
to 230 232 2853 2855 O
screening 233 242 2856 2865 O
may 243 246 2866 2869 O
be 247 249 2870 2872 O
used 250 254 2873 2877 O
, 254 255 2877 2878 O
if 256 258 2879 2881 O
available 259 268 2882 2891 O
. 268 269 2891 2892 O
) 269 270 2892 2893 O

The 0 3 2894 2897 O
participant 4 15 2898 2909 O
has 16 19 2910 2913 O
clinically 20 30 2914 2924 O
significant 31 42 2925 2936 O
abnormalities 43 56 2937 2950 O
detected 57 65 2951 2959 O
on 66 68 2960 2962 O
a 69 70 2963 2964 O
12 71 73 2965 2967 O
- 73 74 2967 2968 O
lead 74 78 2968 2972 O
electrocardiogram 79 96 2973 2990 B-treatment
( 97 98 2991 2992 I-treatment
ECG 98 101 2992 2995 I-treatment
) 101 102 2995 2996 I-treatment
performed 103 112 2997 3006 O
at 113 115 3007 3009 O
the 116 119 3010 3013 O
time 120 124 3014 3018 O
of 125 127 3019 3021 O
screening 128 137 3022 3031 O
. 137 138 3031 3032 O
( 139 140 3033 3034 O
Past 140 144 3034 3038 O
records 145 152 3039 3046 O
obtained 153 161 3047 3055 O
within 162 168 3056 3062 O
26 169 171 3063 3065 B-upper_bound
weeks 172 177 3066 3071 I-upper_bound
prior 178 183 3072 3077 I-upper_bound
to 184 186 3078 3080 O
screening 187 196 3081 3090 O
may 197 200 3091 3094 O
be 201 203 3095 3097 O
used 204 208 3098 3102 O
, 208 209 3102 3103 O
if 210 212 3104 3106 O
available 213 222 3107 3116 O
. 222 223 3116 3117 O
) 223 224 3117 3118 O

The 0 3 3119 3122 O
participant 4 15 3123 3134 O
has 16 19 3135 3138 O
clinically 20 30 3139 3149 O
significant 31 42 3150 3161 O
congestive 43 53 3162 3172 B-chronic_disease
heart 54 59 3173 3178 I-chronic_disease
failure 60 67 3179 3186 I-chronic_disease
with 68 72 3187 3191 O
New 73 76 3192 3195 B-clinical_variable
York 77 81 3196 3200 I-clinical_variable
Heart 82 87 3201 3206 I-clinical_variable
Association 88 99 3207 3218 I-clinical_variable
( 100 101 3219 3220 I-clinical_variable
NYHA 101 105 3220 3224 I-clinical_variable
) 105 106 3224 3225 I-clinical_variable
Class 107 112 3226 3231 I-clinical_variable
III 113 116 3232 3235 B-lower_bound
/ 116 117 3235 3236 O
IV 117 119 3236 3238 B-upper_bound
symptoms 120 128 3239 3247 O

The 0 3 3248 3251 O
participant 4 15 3252 3263 O
has 16 19 3264 3267 O
contraindication(s 20 38 3268 3286 O
) 38 39 3286 3287 O
to 40 42 3288 3290 O
bronchoscopy 43 55 3291 3303 B-treatment
such 56 60 3304 3308 O
as 61 63 3309 3311 O
recent 64 70 3312 3318 O
myocardial 71 81 3319 3329 B-chronic_disease
infarction 82 92 3330 3340 I-chronic_disease
, 92 93 3340 3341 O
unstable 94 102 3342 3350 B-chronic_disease
angina 103 109 3351 3357 I-chronic_disease
, 109 110 3357 3358 O
other 111 116 3359 3364 B-chronic_disease
cardiopulmonary 117 132 3365 3380 I-chronic_disease
instability 133 144 3381 3392 I-chronic_disease
, 144 145 3392 3393 O
tracheal 146 154 3394 3402 B-chronic_disease
obstruction 155 166 3403 3414 I-chronic_disease
or 167 169 3415 3417 O
stenosis 170 178 3418 3426 B-chronic_disease
, 178 179 3426 3427 O
moderate 180 188 3428 3436 O
to 189 191 3437 3439 O
severe 192 198 3440 3446 O
hypoxemia 199 208 3447 3456 B-chronic_disease
or 209 211 3457 3459 O
any 212 215 3460 3463 O
degree 216 222 3464 3470 O
of 223 225 3471 3473 O
hypercapnia 226 237 3474 3485 B-chronic_disease
, 237 238 3485 3486 O
unstable 239 247 3487 3495 O
asthma 248 254 3496 3502 B-chronic_disease
, 254 255 3502 3503 O
Stage 256 261 3504 3509 B-chronic_disease
4 262 263 3510 3511 I-chronic_disease
or 264 266 3512 3514 I-chronic_disease
5 267 268 3515 3516 I-chronic_disease
chronic 269 276 3517 3524 I-chronic_disease
kidney 277 283 3525 3531 I-chronic_disease
disease 284 291 3532 3539 I-chronic_disease
, 291 292 3539 3540 O
pulmonary 293 302 3541 3550 B-chronic_disease
hypertension 303 315 3551 3563 I-chronic_disease
, 315 316 3563 3564 O
severe 317 323 3565 3571 O
hemorrhagic 324 335 3572 3583 B-chronic_disease
diathesis 336 345 3584 3593 I-chronic_disease
, 345 346 3593 3594 O
and 347 350 3595 3598 O
cervical 351 359 3599 3607 B-chronic_disease
C1 360 362 3608 3610 I-chronic_disease
/ 362 363 3610 3611 I-chronic_disease
C2 363 365 3611 3613 I-chronic_disease
arthritis 366 375 3614 3623 I-chronic_disease

The 0 3 3624 3627 O
participant 4 15 3628 3639 O
has 16 19 3640 3643 O
had 20 23 3644 3647 O
lung 24 28 3648 3652 B-treatment
surgery 29 36 3653 3660 I-treatment
which 37 42 3661 3666 O
may 43 46 3667 3670 O
interfere 47 56 3671 3680 O
with 57 61 3681 3685 O
bronchoscopy 62 74 3686 3698 B-chronic_disease

The 0 3 3699 3702 O
participant 4 15 3703 3714 O
has 16 19 3715 3718 O
participated 20 32 3719 3731 O
in 33 35 3732 3734 O
another 36 43 3735 3742 B-treatment
clinical 44 52 3743 3751 I-treatment
study 53 58 3752 3757 I-treatment
involving 59 68 3758 3767 O
an 69 71 3768 3770 O
investigational 72 87 3771 3786 B-treatment
product 88 95 3787 3794 I-treatment
or 96 98 3795 3797 O
investigational 99 114 3798 3813 B-treatment
device 115 121 3814 3820 I-treatment
within 122 128 3821 3827 O
30 129 131 3828 3830 B-upper_bound
days 132 136 3831 3835 I-upper_bound
prior 137 142 3836 3841 I-upper_bound
to 143 145 3842 3844 O
enrollment 146 156 3845 3855 O
or 157 159 3856 3858 O
is 160 162 3859 3861 O
scheduled 163 172 3862 3871 O
to 173 175 3872 3874 O
participate 176 187 3875 3886 O
in 188 190 3887 3889 O
another 191 198 3890 3897 O
clinical 199 207 3898 3906 O
study 208 213 3907 3912 O
involving 214 223 3913 3922 O
an 224 226 3923 3925 O
investigational 227 242 3926 3941 O
product 243 250 3942 3949 O
or 251 253 3950 3952 O
device 254 260 3953 3959 O
during 261 267 3960 3966 O
the 268 271 3967 3970 O
course 272 278 3971 3977 O
of 279 281 3978 3980 O
this 282 286 3981 3985 O
study 287 292 3986 3991 O

The 0 3 3992 3995 O
participant 4 15 3996 4007 O
is 16 18 4008 4010 O
a 19 20 4011 4012 O
nonsmoker 21 30 4013 4022 O
or 31 33 4023 4025 O
has 34 37 4026 4029 O
ceased 38 44 4030 4036 O
smoking 45 52 4037 4044 O
for 53 56 4045 4048 O
a 57 58 4049 4050 O
minimum 59 66 4051 4058 O
of 67 69 4059 4061 O
13 70 72 4062 4064 B-lower_bound
weeks 73 78 4065 4070 I-lower_bound
prior 79 84 4071 4076 I-lower_bound
to 85 87 4077 4079 O
screening 88 97 4080 4089 O
( 98 99 4090 4091 O
serum 99 104 4091 4096 O
cotinine 105 113 4097 4105 O
level 114 119 4106 4111 O
at 120 122 4112 4114 O
screening 123 132 4115 4124 O
within 133 139 4125 4131 O
normal 140 146 4132 4138 O
range 147 152 4139 4144 O
of 153 155 4145 4147 O
a 156 157 4148 4149 O
nonsmoker 158 167 4150 4159 O
) 167 168 4159 4160 O
and 169 172 4161 4164 O
agrees 173 179 4165 4171 O
to 180 182 4172 4174 O
refrain 183 190 4175 4182 O
from 191 195 4183 4187 O
smoking 196 203 4188 4195 O
throughout 204 214 4196 4206 O
the 215 218 4207 4210 O
course 219 225 4211 4217 O
of 226 228 4218 4220 O
the 229 232 4221 4224 O
study 233 238 4225 4230 O
. 238 239 4230 4231 O
Participants 240 252 4232 4244 O
with 253 257 4245 4249 O
a 258 259 4250 4251 O
positive 260 268 4252 4260 O
cotinine 269 277 4261 4269 B-treatment
test 278 282 4270 4274 I-treatment
due 283 286 4275 4278 O
to 287 289 4279 4281 O
nicotine 290 298 4282 4290 B-treatment
replacement 299 310 4291 4302 I-treatment
therapy 311 318 4303 4310 I-treatment
( 319 320 4311 4312 O
eg 320 322 4312 4314 O
, 322 323 4314 4315 O
patches 324 331 4316 4323 O
, 331 332 4323 4324 O
chewing 333 340 4325 4332 O
gum 341 344 4333 4336 O
) 344 345 4336 4337 O
, 345 346 4337 4338 O
vapor 347 352 4339 4344 O
cigarettes 353 363 4345 4355 O
, 363 364 4355 4356 O
or 365 367 4357 4359 O
snuff 368 373 4360 4365 O
are 374 377 4366 4369 O
eligible 378 386 4370 4378 O

The 0 3 4379 4382 O
participant 4 15 4383 4394 O
is 16 18 4395 4397 O
experiencing 19 31 4398 4410 O
a 32 33 4411 4412 O
pulmonary 34 43 4413 4422 B-chronic_disease
exacerbation 44 56 4423 4435 I-chronic_disease
at 57 59 4436 4438 O
the 60 63 4439 4442 O
time 64 68 4443 4447 O
of 69 71 4448 4450 O
screening 72 81 4451 4460 O
( 82 83 4461 4462 O
participant 83 94 4462 4473 O
may 95 98 4474 4477 O
be 99 101 4478 4480 O
re 102 104 4481 4483 O
- 104 105 4483 4484 O
screened 105 113 4484 4492 O
4 114 115 4493 4494 B-upper_bound
weeks 116 121 4495 4500 I-upper_bound
after 122 127 4501 4506 I-upper_bound
the 128 131 4507 4510 O
clinical 132 140 4511 4519 O
resolution 141 151 4520 4530 O
of 152 154 4531 4533 O
an 155 157 4534 4536 O
exacerbation 158 170 4537 4549 O
) 170 171 4549 4550 O

The 0 3 4551 4554 O
participant 4 15 4555 4566 O
is 16 18 4567 4569 O
experiencing 19 31 4570 4582 O
an 32 34 4583 4585 O
active 35 41 4586 4592 O
malignancy 42 52 4593 4603 B-cancer
or 53 55 4604 4606 O
has 56 59 4607 4610 O
a 60 61 4611 4612 O
history 62 69 4613 4620 O
of 70 72 4621 4623 O
malignancy 73 83 4624 4634 O
within 84 90 4635 4641 O
5 91 92 4642 4643 B-upper_bound
years 93 98 4644 4649 I-upper_bound
prior 99 104 4650 4655 I-upper_bound
to 105 107 4656 4658 O
screening 108 117 4659 4668 O
, 117 118 4668 4669 O
with 119 123 4670 4674 O
the 124 127 4675 4678 O
exception 128 137 4679 4688 O
of 138 140 4689 4691 O
the 141 144 4692 4695 O
following 145 154 4696 4705 O
: 154 155 4705 4706 O
adequately 156 166 4707 4717 O
treated 167 174 4718 4725 O
basal 175 180 4726 4731 B-cancer
cell 181 185 4732 4736 I-cancer
or 186 188 4737 4739 O
squamous 189 197 4740 4748 B-cancer
cell 198 202 4749 4753 I-cancer
carcinoma 203 212 4754 4763 I-cancer
of 213 215 4764 4766 I-cancer
the 216 219 4767 4770 I-cancer
skin 220 224 4771 4775 I-cancer
, 224 225 4775 4776 O
carcinoma 226 235 4777 4786 B-cancer
in 236 238 4787 4789 I-cancer
situ 239 243 4790 4794 I-cancer
of 244 246 4795 4797 I-cancer
the 247 250 4798 4801 I-cancer
cervix 251 257 4802 4808 I-cancer
, 257 258 4808 4809 O
or 259 261 4810 4812 O
stable 262 268 4813 4819 O
prostate 269 277 4820 4828 B-cancer
cancer 278 284 4829 4835 I-cancer
not 285 288 4836 4839 O
requiring 289 298 4840 4849 O
treatment 299 308 4850 4859 B-treatment

The 0 3 4860 4863 O
participant 4 15 4864 4875 O
is 16 18 4876 4878 O
experiencing 19 31 4879 4891 O
or 32 34 4892 4894 O
has 35 38 4895 4898 O
a 39 40 4899 4900 O
history 41 48 4901 4908 O
of 49 51 4909 4911 O
chronic 52 59 4912 4919 O
severe 60 66 4920 4926 O
cor 67 70 4927 4930 B-chronic_disease
pulmonale 71 80 4931 4940 I-chronic_disease
( 81 82 4941 4942 O
resting 82 89 4942 4949 O
mean 90 94 4950 4954 O
pulmonary 95 104 4955 4964 B-clinical_variable
artery 105 111 4965 4971 I-clinical_variable
pressure 112 120 4972 4980 I-clinical_variable
≥40 121 124 4981 4984 O
millimeter(s 125 137 4985 4997 I-lower_bound
) 137 138 4997 4998 I-lower_bound
of 139 141 4999 5001 I-lower_bound
mercury 142 149 5002 5009 I-lower_bound
( 150 151 5010 5011 I-lower_bound
mm 151 153 5011 5013 I-lower_bound
Hg 154 156 5014 5016 I-lower_bound
) 156 157 5016 5017 I-lower_bound
) 157 158 5017 5018 O

The 0 3 5019 5022 O
participant 4 15 5023 5034 O
is 16 18 5035 5037 O
experiencing 19 31 5038 5050 O
or 32 34 5051 5053 O
has 35 38 5054 5057 O
a 39 40 5058 5059 O
history 41 48 5060 5067 O
of 49 51 5068 5070 O
clinically 52 62 5071 5081 O
significant 63 74 5082 5093 O
pulmonary 75 84 5094 5103 B-chronic_disease
disease 85 92 5104 5111 I-chronic_disease
( 93 94 5112 5113 O
other 94 99 5113 5118 O
than 100 104 5119 5123 O
chronic 105 112 5124 5131 B-chronic_disease
obstructive 113 124 5132 5143 I-chronic_disease
pulmonary 125 134 5144 5153 I-chronic_disease
disease 135 142 5154 5161 I-chronic_disease
( 143 144 5162 5163 I-chronic_disease
COPD 144 148 5163 5167 I-chronic_disease
) 148 149 5167 5168 I-chronic_disease
, 149 150 5168 5169 O
emphysema 151 160 5170 5179 B-chronic_disease
, 160 161 5179 5180 O
chronic 162 169 5181 5188 B-chronic_disease
bronchitis 170 180 5189 5199 I-chronic_disease
, 180 181 5199 5200 O
mild 182 186 5201 5205 O
bronchiectasis 187 201 5206 5220 B-chronic_disease
, 201 202 5220 5221 O
and 203 206 5222 5225 O
stable 207 213 5226 5232 O
asthma 214 220 5233 5239 B-chronic_disease
) 220 221 5239 5240 O

The 0 3 5241 5244 O
participant 4 15 5245 5256 O
is 16 18 5257 5259 O
receiving 19 28 5260 5269 O
long 29 33 5270 5274 B-treatment
- 33 34 5274 5275 I-treatment
term 34 38 5275 5279 I-treatment
around 39 45 5280 5286 I-treatment
- 45 46 5286 5287 I-treatment
the 46 49 5287 5290 I-treatment
- 49 50 5290 5291 I-treatment
clock 50 55 5291 5296 I-treatment
oxygen 56 62 5297 5303 I-treatment
supplementation 63 78 5304 5319 I-treatment
. 78 79 5319 5320 O
( 80 81 5321 5322 O
The 81 84 5322 5325 O
following 85 94 5326 5335 O
are 95 98 5336 5339 O
allowed 99 106 5340 5347 O
: 106 107 5347 5348 O
short 108 113 5349 5354 O
- 113 114 5354 5355 O
term 114 118 5355 5359 O
use 119 122 5360 5363 O
of 123 125 5364 5366 O
oxygen 126 132 5367 5373 O
supplementation 133 148 5374 5389 O
[ 149 150 5390 5391 O
eg 150 152 5391 5393 O
, 152 153 5393 5394 O
for 154 157 5395 5398 O
the 158 161 5399 5402 O
management 162 172 5403 5413 O
of 173 175 5414 5416 O
acute 176 181 5417 5422 B-treatment
COPD 182 186 5423 5427 I-treatment
exacerbation 187 199 5428 5440 I-treatment
] 199 200 5440 5441 O
, 200 201 5441 5442 O
oxygen 202 208 5443 5449 O
supplementation 209 224 5450 5465 O
required 225 233 5466 5474 O
during 234 240 5475 5481 O
night 241 246 5482 5487 O
time 247 251 5488 5492 O
only 252 256 5493 5497 O
, 256 257 5497 5498 O
and 258 261 5499 5502 O
supplemental 262 274 5503 5515 B-treatment
oxygen 275 281 5516 5522 I-treatment
( 282 283 5523 5524 I-treatment
O2 283 285 5524 5526 I-treatment
) 285 286 5526 5527 I-treatment
with 287 291 5528 5532 I-treatment
continuous 292 302 5533 5543 I-treatment
positive 303 311 5544 5552 I-treatment
airway 312 318 5553 5559 I-treatment
pressure 319 327 5560 5568 I-treatment
[ 328 329 5569 5570 I-treatment
CPAP 329 333 5570 5574 I-treatment
] 333 334 5574 5575 I-treatment
or 335 337 5576 5578 O
bi 338 340 5579 5581 B-treatment
- 340 341 5581 5582 I-treatment
level 341 346 5582 5587 I-treatment
positive 347 355 5588 5596 I-treatment
airway 356 362 5597 5603 I-treatment
pressure 363 371 5604 5612 I-treatment
[ 372 373 5613 5614 I-treatment
BiPAP 373 378 5614 5619 I-treatment
] 378 379 5619 5620 I-treatment
) 379 380 5620 5621 I-treatment

The 0 3 5622 5625 O
participant 4 15 5626 5637 O
is 16 18 5638 5640 O
receiving 19 28 5641 5650 O
or 29 31 5651 5653 O
requires 32 40 5654 5662 O
long 41 45 5663 5667 O
- 45 46 5667 5668 O
term 46 50 5668 5672 O
( 51 52 5673 5674 O
> 52 53 5674 5675 O
4 53 54 5675 5676 B-lower_bound
weeks 55 60 5677 5682 I-lower_bound
) 60 61 5682 5683 O
immunosuppressive 62 79 5684 5701 B-treatment
therapy 80 87 5702 5709 I-treatment
, 87 88 5709 5710 O
such 89 93 5711 5715 O
as 94 96 5716 5718 O
systemic 97 105 5719 5727 B-treatment
corticosteroids 106 121 5728 5743 I-treatment
at 122 124 5744 5746 O
doses 125 130 5747 5752 O
greater 131 138 5753 5760 O
than 139 143 5761 5765 O
10 144 146 5766 5768 B-lower_bound
mg 147 149 5769 5771 I-lower_bound
/ 149 150 5771 5772 I-lower_bound
day 150 153 5772 5775 I-lower_bound
of 154 156 5776 5778 O
prednisone 157 167 5779 5789 B-treatment
( 168 169 5790 5791 O
or 169 171 5791 5793 O
its 172 175 5794 5797 O
equivalent 176 186 5798 5808 O
) 186 187 5808 5809 O
, 187 188 5809 5810 O
mycophenolate 189 202 5811 5824 B-treatment
mofetil 203 210 5825 5832 I-treatment
, 210 211 5832 5833 O
azathioprine 212 224 5834 5846 B-treatment
, 224 225 5846 5847 O
cyclophosphamide 226 242 5848 5864 B-treatment
, 242 243 5864 5865 O
and 244 247 5866 5869 O
rituximab 248 257 5870 5879 B-treatment

The 0 3 5880 5883 O
participant 4 15 5884 5895 O
routinely 16 25 5896 5905 O
produces 26 34 5906 5914 O
more 35 39 5915 5919 O
than 40 44 5920 5924 O
1 45 46 5925 5926 B-lower_bound
tablespoon 47 57 5927 5937 I-lower_bound
of 58 60 5938 5940 O
sputum 61 67 5941 5947 B-chronic_disease
per 68 71 5948 5951 O
day 72 75 5952 5955 O

female 0 6 5956 5962 B-gender

